Research / WVVI / Fundamental state Inspectable configuration
State dimensions Filing 0001199835-26-000283 General Corporate
Debt relative to revenue 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
144.85% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.28% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.43% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-1.56% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
314.03% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
57.53% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-13.49% · CORE · VALID
SBC intensity 55th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.21% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 37 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 179.03%
Current 144.85%
Delta -34.18% Capex Intensity Decreased
Previous 0.60%
Current 0.28%
Delta -0.32% Cash Generation Increased
Previous 9.63%
Current 19.43%
Delta 9.81% Growth Decreased
Previous 9.48%
Current -1.56%
Delta -11.04% Inventory Pressure Decreased
Previous 392.81%
Current 314.03%
Delta -78.77% Margin Decreased
Previous 60.91%
Current 57.53%
Delta -3.38% Profitability Decreased
Previous -8.21%
Current -13.49%
Delta -5.28% Sbc Intensity Decreased
Previous 0.25%
Current 0.21%
Delta -0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2026
Similarity 74%
Compared 8 dimensions
Coverage 100% Growth 40.0 · Margin 55.0 · Profitability 10.0 · Sbc Intensity 5.5 · Capex Intensity 0.0 · Cash Generation 10.0 · Inventory Pressure 25.0 · Balance Sheet Leverage 10.0 Jun 30, 2019
Similarity 73%
Compared 6 dimensions
Coverage 75% Margin 12.5 · Profitability 10.0 · Capex Intensity 12.5 · Cash Generation 27.5 · Inventory Pressure 10.0 · Balance Sheet Leverage 55.0 Jun 30, 2025
Similarity 72%
Compared 7 dimensions
Coverage 88% Growth 0.0 · Margin 45.0 · Profitability 50.0 · Capex Intensity 0.0 · Cash Generation 15.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 15.0 Jun 30, 2023
Similarity 67%
Compared 7 dimensions
Coverage 88% Growth 55.0 · Margin 0.0 · Profitability 10.0 · Capex Intensity 0.0 · Cash Generation 40.0 · Inventory Pressure 35.0 · Balance Sheet Leverage 40.0 Mar 31, 2021
Similarity 66%
Compared 7 dimensions
Coverage 88% Growth 25.0 · Margin 1.7 · Profitability 10.0 · Capex Intensity 0.0 · Cash Generation 76.7 · Inventory Pressure 21.7 · Balance Sheet Leverage 33.3 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.